All Stories

  1. The links between soil and water pollution and cardiovascular disease
  2. Environmental Hypertensionology and the Mosaic Theory of Hypertension
  3. Transportation noise and the cardiometabolic risk
  4. Interventions by Cardiovascular Drugs Against Aircraft Noise-Induced Cardiovascular Oxidative Stress and Damage
  5. How quitting, switching to e-cigarettes, or sticking to smoking shapes cardiovascular outcomes after percutaneous coronary intervention
  6. “Split Impact: Road Traffic Directly Strains the Heart, Railway Noise Fuels Metabolic Risk—The Need for Tailored Noise Control”
  7. Challenges posed by climate hazards to cardiovascular health and cardiac intensive care: implications for mitigation and adaptation
  8. Soil and water pollution and cardiovascular disease
  9. Effects of Short-Term Gluten-Free Diet on Cardiovascular Biomarkers and Quality of Life in Healthy Individuals: A Prospective Interventional Study
  10. Pathomechanistic Synergy Between Particulate Matter and Traffic Noise-Induced Cardiovascular Damage and the Classical Risk Factor Hypertension
  11. Incidence and impact of venous thromboembolism in hospitalized patients with acute pancreatitis
  12. Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure
  13. Transportation Noise Pollution and Cardiovascular Health
  14. Injection Site Matters: A Comparative Analysis of Transpulmonary Thermodilution via Simultaneous Femoral and Jugular Indicator Injections under Veno-Venous Extracorporeal Membrane Oxygenation Therapy
  15. The Urban Environment and Cardiometabolic Health
  16. Drivers and recent trends of hospitalisation costs related to acute pulmonary embolism
  17. Crosstalk between Oxidative Stress and Inflammation Caused by Noise and Air Pollution—Implications for Neurodegenerative Diseases
  18. Breathing danger: linking air pollution to cardiovascular disease and increased risk of abdominal aortic aneurysm
  19. Coding Hypertension by Nicotine: Unraveling the Sex-Specific Role Of m6A Demethylase for NOX2 RNA-Protein Connection
  20. Air pollution deaths attributable to fossil fuels: observational and modelling study
  21. Clearing the air, saving lives: understanding air pollution’s impact on out-of-hospital cardiac arrest
  22. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk
  23. Air Pollution and Neuropsychiatric Disease
  24. Noise Pollution and Neuropsychiatric Disease
  25. Oxidative Stress and Inflammation Contribute to Traffic Noise-Induced Vascular and Cerebral Dysfunction via Uncoupling of Nitric Oxide Synthases
  26. The Exposome Concept
  27. Late-Onset Prosthetic Endocarditis with Paraaortic Abscess Caused by Cutibacterium acnes
  28. Development and Phenotype of Heart Failure in Long‐Term Survivors of Childhood Cancer: The CVSS Study
  29. Cumulative social disadvantage and cardiovascular disease burden and mortality
  30. Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function
  31. Diabetes Mellitus and Its Association with Adverse In-Hospital Outcomes in Patients with COVID-19—A Nationwide Study
  32. The contribution of the exposome to the burden of cardiovascular disease
  33. Environmental Stressors and the Endothelium
  34. E-cigarette effects on vascular function in animals and humans
  35. Noise and Air Pollution as Risk Factors for Hypertension: Part II—Pathophysiologic Insight
  36. Noise and Air Pollution as Risk Factors for Hypertension: Part I—Epidemiology
  37. Vascular Redox Signaling, Endothelial Nitric Oxide Synthase Uncoupling, and Endothelial Dysfunction in the Setting of Transportation Noise Exposure or Chronic Treatment with Organic Nitrates
  38. Noise, Air, and Heavy Metal Pollution as Risk Factors for Endothelial Dysfunction
  39. The emergence of the air pollutant ozone as a significant cardiovascular killer?
  40. Early Detection Is the Best Prevention—Characterization of Oxidative Stress in Diabetes Mellitus and Its Consequences on the Cardiovascular System
  41. CRB-65 for Risk Stratification and Prediction of Prognosis in Pulmonary Embolism
  42. Extracorporeal CPR in Out-of-Hospital Cardiac Arrest — Still on Life Support?
  43. Are e-cigarettes dangerous or do they boost our health: no END(S) of the discussion in sight
  44. Case Fatality of Hospitalized Patients with COVID-19 Infection Suffering from Acute Respiratory Distress Syndrome in Germany
  45. Temporal Trends in Patients with Peripheral Artery Disease Influenced by COVID-19 Pandemic
  46. Acute Exposure to Simulated Nocturnal Train Noise Leads to Impaired Sleep Quality and Endothelial Dysfunction in Young Healthy Men and Women: A Sex-Specific Analysis
  47. Arginase-1 Deletion in Erythrocytes Promotes Vascular Calcification via Enhanced GSNOR (S-Nitrosoglutathione Reductase) Expression and NO Signaling in Smooth Muscle Cells
  48. Those declared dead live longer
  49. Case-Fatality and Temporal Trends in Patients with Psoriasis and End-Stage Renal Disease
  50. Soil and water pollution and human health: what should cardiologists worry about?
  51. Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series
  52. Measurement of Tetrahydrobiopterin in Animal Tissue Samples by HPLC with Electrochemical Detection—Protocol Optimization and Pitfalls
  53. EPCR−PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia
  54. The manual of cardiovascular medicine, Oxford University Press 2022: just a pocket guide but ‘all inclusive’
  55. Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis
  56. Mechanistic Insights into Inorganic Nitrite-Mediated Vasodilation of Isolated Aortic Rings under Oxidative/Hypertensive Conditions and S-Nitros(yl)ation of Proteins in Germ-Free Mice
  57. Short and Concise Peer-to-Peer Teaching—Example of a Successful Antibiotic Stewardship Intervention to Increase Iv to Po Conversion
  58. Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
  59. Endothelial dysfunction: basis for many local and systemic conditions
  60. Influence of Peripheral Transluminal Angioplasty Alongside Exercise Training on Oxidative Stress and Inflammation in Patients with Peripheral Arterial Disease
  61. Lack of Endothelial α1AMPK Reverses the Vascular Protective Effects of Exercise by Causing eNOS Uncoupling
  62. Reduced Aircraft Noise Pollution During COVID-19 Lockdown Is Beneficial to Public Cardiovascular Health: a Perspective on the Reduction of Transportation-Associated Pollution
  63. Sleepless in Seattle: Sleep Deprivation and Fragmentation Impair Endothelial Function and Fibrinolysis in Hypertension
  64. Das Exposom charakterisiert die Auswirkungen unserer Umwelt auf Stoffwechsel und Gesundheit
  65. Gesundheitsrisiko Mobilfunkstrahlung? Was ändert sich mit 5G?
  66. Herzgesunde Städte – die Gene laden das Gewehr, die Umwelt zieht den Abzug
  67. Lebensstil und kardiovaskuläre Gesundheit – wie schädlich sind E-Zigaretten und Shisha-Rauchen?
  68. Long-Term Exposure to Transportation Noise and Risk for Type 2 Diabetes in a Nationwide Cohort Study from Denmark
  69. Luftverschmutzung und Herz-Kreislauf-Erkrankungen
  70. Lärm und Herz-Kreislauf-Erkrankungen
  71. Nachtlärminduzierte Schlafstörungen und Herz-Kreislauf-Risiko
  72. Risk Factors for Pulmonary Embolism in Patients with Paralysis and Deep Venous Thrombosis
  73. Effectiveness of a Real-Time X-ray Dosimetry Monitor in Reducing Radiation Exposure in Coronary Procedures: The ESPRESSO-Raysafe Randomized Trial
  74. B Lymphocyte-Deficiency in Mice Causes Vascular Dysfunction by Inducing Neutrophilia
  75. Physical Activity in Polluted Air—Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review
  76. Association of Birth Weight with Central and Peripheral Corneal Thickness in Adulthood—Results from the Population-Based German Gutenberg Health Study
  77. Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease
  78. Disturbed Lipid Metabolism in Diabetic Patients with Manifest Coronary Artery Disease Is Associated with Enhanced Inflammation
  79. Environmental risk factors and cardiovascular diseases: a comprehensive expert review
  80. Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population
  81. GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation
  82. Long-Term Outcome with New Generation Prostheses in Patients Undergoing Transcatheter Aortic Valve Replacement
  83. A pathophysiological compass to personalize antianginal drug treatment
  84. Non‐bacterial thrombotic endocarditis in a patient with pancreatic carcinoma
  85. Smoking and Neuropsychiatric Disease—Associations and Underlying Mechanisms
  86. Takotsubo Syndrome: Impact of endothelial dysfunction and oxidative stress
  87. Effects of Dietary Protein Intake on Cutaneous and Systemic Inflammation in Mice with Acute Experimental Psoriasis
  88. Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry
  89. Heart healthy cities: genetics loads the gun but the environment pulls the trigger
  90. Role of angiopoietin-2 in venous thrombus resolution and chronic thromboembolic disease
  91. Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study
  92. Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism
  93. Running in polluted air is a two-edged sword — physical exercise in low air pollution areas is cardioprotective but detrimental for the heart in high air pollution areas
  94. Detection of extracellular superoxide in isolated human immune cells and in an animal model of arterial hypertension using hydropropidine probe and HPLC analysis
  95. Noise-Induced Vascular Dysfunction, Oxidative Stress, and Inflammation Are Improved by Pharmacological Modulation of the NRF2/HO-1 Axis
  96. Transportation noise pollution and cardiovascular disease
  97. ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure
  98. Accelerated Aging and Age-Related Diseases (CVD and Neurological) due to Air Pollution and Traffic Noise Exposure
  99. The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with Chronic Total Occlusion Evaluated by Clinical Outcome and Optical Coherence Tomography Imaging Analysis
  100. Ambient Air Pollution and Atherosclerosis
  101. In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism
  102. CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
  103. Reduction of environmental pollutants for prevention of cardiovascular disease: it’s time to act
  104. Regional and global contributions of air pollution to risk of death from COVID-19
  105. Environmental Factors Such as Noise and Air Pollution and Vascular Disease
  106. Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy
  107. Psoriasis and Its Impact on In-Hospital Outcome in Patients Hospitalized with Acute Kidney Injury
  108. Impact of Psoriasis on Mortality Rate and Outcome in Myocardial Infarction
  109. Association of transcatheter direct mitral annuloplasty with acute anatomic, haemodynamic, and clinical outcomes in severe mitral valve regurgitation
  110. Recalled parental rearing behavior in adult women and men with depressive and anxiety symptoms: Findings from a community study
  111. Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample
  112. Impact of concomitant deep or superficial venous thrombosis of the legs on survival of patients with pulmonary embolism
  113. Could E-cigarette vaping contribute to heart disease?
  114. Peripapillary Retinal Nerve Fiber Layer Profile in Relation to Refractive Error and Axial Length: Results From the Gutenberg Health Study
  115. T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction
  116. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest Pain Units“
  117. Feasibility of a MPR‐based 3DTEE guidance protocol for transcatheter direct mitral valve annuloplasty
  118. Auswirkungen von Umweltrisikofaktoren wie Lärm und Luftverschmutzung auf die psychische Gesundheit: Was wissen wir?
  119. Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia
  120. Long-term residential road traffic noise and mortality in a Danish cohort
  121. Prevalence of Strabismus and Its Impact on Vision-Related Quality of Life
  122. Symptoms of depersonalization/derealization are independent risk factors for the development or persistence of psychological distress in the general population: Results from the Gutenberg health study
  123. Sex-dependent associations of low birth weight and suicidal ideation in adulthood: a community-based cohort study
  124. Neochord anterior leaflet treatment to facilitate transcatheter mitral valve replacement with 3D real-time echocardiography
  125. EkoSonic® endovascular system and other catheter-directed treatment reperfusion strategies for acute pulmonary embolism: overview of efficacy and safety outcomes
  126. Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients
  127. The association of chronic anxiousness with cardiovascular disease and mortality in the community: results from the Gutenberg Health Study
  128. Transcatheter left ventricular reshape of apical ischaemic aneurysm achieves left ventricular remodelling, improves wall motion, causes papillary muscle approximation, and a reduction of secondary MVR
  129. The association between recalled parental rearing behavior and depressiveness: a comparison between 1st immigrants and non-immigrants in the population-based Gutenberg Health Study
  130. Association of Birth Weight with Peripapillary Retinal Nerve Fiber Layer Thickness in Adulthood—Results from a Population-Based Study
  131. Exacerbation of adverse cardiovascular effects of aircraft noise in an animal model of arterial hypertension
  132. Isolated Pulmonary Embolism Is Associated With a High Risk of Arterial Thrombotic Disease
  133. Novel Concept for the Regulation of eNOS (Endothelial Nitric Oxide Synthase) Activity
  134. Oxidative stress and inflammation contribute to traffic noise-induced vascular and cerebral dysfunction via uncoupling of nitric oxide synthases
  135. Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany
  136. Inappropriate evaluation of methodology and biases by P. Morfeld and T.C. Erren
  137. Prevalence of pterygium and identification of associated factors in a German population – results from the Gutenberg Health Study
  138. Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism
  139. Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab
  140. Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress
  141. The AMP-Activated Protein Kinase Plays a Role in Antioxidant Defense and Regulation of Vascular Inflammation
  142. Cardiovascular health outcomes of mobbing at work: results of the population-based, five-year follow-up of the Gutenberg health study
  143. Interplay of the red blood cell and vascular endothelial nitric oxide synthase system to combat cardiac complications of anemia
  144. Predictors of short‐ and long‐term outcomes of patients undergoing transcatheter mitral valve edge‐to‐edge repair
  145. Frequency of cataract surgery and its impact on visual function—results from the German Gutenberg Health Study
  146. Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
  147. Corrigendum
  148. Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial
  149. Venous thromboembolism in patients hospitalized for hip joint replacement surgery
  150. Capacity changes in German certified chest pain units during COVID-19 outbreak response
  151. Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failure
  152. Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase—Implications for Diabetes Progression
  153. Development of an Analytical Assay for Electrochemical Detection and Quantification of Protein-Bound 3-Nitrotyrosine in Biological Samples and Comparison with Classical, Antibody-Based Methods
  154. Coronary stent thrombosis—predictors and prevention
  155. Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr
  156. Road Traffic Noise Exposure and Filled Prescriptions for Antihypertensive Medication: A Danish Cohort Study
  157. Bevölkerungsbezogene psychische Gesundheit als Schlüsselfaktor im Umgang mit COVID-19
  158. Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away
  159. Renal Effects of Fetal Reprogramming With Pentaerythritol Tetranitrate in Spontaneously Hypertensive Rats
  160. Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
  161. No evidence for an association of plasma homocysteine levels and refractive error – Results from the population-based Gutenberg Health Study (GHS)
  162. Corrigendum
  163. Adverse Cardiovascular Effects of Traffic Noise with a Focus on Nighttime Noise and the New WHO Noise Guidelines
  164. Environmental aircraft noise aggravates oxidative DNA damage, granulocyte oxidative burst and nitrate resistance in Ogg1–/– mice
  165. Resting and recruitable endothelial function – Evidence of two distinct circadian patterns
  166. Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany
  167. Age-Related Variations in Takotsubo Syndrome
  168. German chest pain unit registry: data review after the first decade of certification
  169. Acrolein, e-cigarettes, and pulmonary and vascular damage
  170. Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study
  171. Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds
  172. Prevalence and new onset of depression and anxiety among participants with AMD in a European cohort
  173. Loss of life expectancy from air pollution compared to other risk factors: a worldwide perspective
  174. Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
  175. Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients
  176. Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database
  177. Specialized Management of Oral Anticoagulation Therapy Improves Outcome in Patients with Chronic Renal Insufficiency
  178. Air pollution, the underestimated cardiovascular risk factor
  179. Long-term cardiovascular risk of e-cigarettes
  180. Frequency of stressful life events and associations with mental health and general subjective health in the general population
  181. Noise annoyance predicts symptoms of depression, anxiety and sleep disturbance 5 years later. Findings from the Gutenberg Health Study
  182. Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection
  183. Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry
  184. Quality benchmarks for chest pain units and stroke units in Germany
  185. Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
  186. Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1
  187. QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method
  188. Predictors for Target Vessel Failure after Recanalization of Chronic Total Occlusions in Patients Undergoing Surveillance Coronary Angiography
  189. Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study
  190. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
  191. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
  192. Gender Differences in Patients Admitted to a Certified German Chest Pain Unit: Results from the German Chest Pain Unit Registry
  193. Schirmer test results: are they associated with topical or systemic medication?
  194. Traffic-related environmental risk factors and their impact on oxidative stress and cardiovascular health
  195. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
  196. Age-Dependent and -Independent Effects of Perivascular Adipose Tissue and Its Paracrine Activities during Neointima Formation
  197. The sixth sense is involved in noise-induced stress responses and vascular inflammation: evidence for heightened amygdalar activity in response to transport noise in man
  198. Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure
  199. Thrombin generation in cardiovascular disease and mortality - results from the Gutenberg Health Study
  200. KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern
  201. Association between medicated obstructive pulmonary disease, depression and subjective health: results from the population-based Gutenberg Health Study
  202. Course of depressive symptoms in men and women: differential effects of social, psychological, behavioral and somatic predictors
  203. Low Birth Weight Is Linked to Age-Related Macular Degeneration: Results From the Population-Based Gutenberg Health Study (GHS)
  204. Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2)
  205. Environmental Noise-Induced Effects on Stress Hormones, Oxidative Stress, and Vascular Dysfunction: Key Factors in the Relationship between Cerebrocardiovascular and Psychological Disorders
  206. Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry
  207. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
  208. Characteristics and pathologies of the vitreo‐macular interface—results from the Gutenberg Health Study
  209. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial
  210. Intact Visuospatial Cognition in Amblyopia: Results From the Gutenberg Health Study
  211. The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes
  212. Transcatheter Mitral Valve Repair: Single Stage Combo Approach
  213. Acute exposure to nocturnal train noise induces endothelial dysfunction and pro-thromboinflammatory changes of the plasma proteome in healthy subjects
  214. Comparison of Mitochondrial Superoxide Detection Ex Vivo/In Vivo by mitoSOX HPLC Method with Classical Assays in Three Different Animal Models of Oxidative Stress
  215. The air pollution constituent particulate matter (PM2.5) destabilizes coronary artery plaques
  216. Endothelial Function Assessed by Digital Volume Plethysmography Predicts the Development and Progression of Type 2 Diabetes Mellitus
  217. Luftverschmutzung und Herz-Kreislauf-System
  218. Advanced Protocol for Three-Dimensional Transesophageal Echocardiography Guidance Implementing Real-Time Multiplanar Reconstruction for Transcatheter Mitral Valve Repair by Direct Annuloplasty
  219. Obesity paradox in peripheral artery disease
  220. Survival Benefit of Obese Patients With Pulmonary Embolism
  221. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
  222. The “exposome” concept – how environmental risk factors influence cardiovascular health
  223. The harms to health caused by aviation noise require urgent action
  224. A prospective cohort study to identify and evaluate endotypes of venous thromboembolism: Rationale and design of the Genotyping and Molecular Phenotyping in Venous ThromboEmbolism project (GMP-VTE)
  225. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome
  226. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
  227. Linking cancer and mental health in men and women in a representative community sample
  228. Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and Inflammation
  229. Reply to ‘Relationship between stent fracture and thrombosis’
  230. Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score
  231. Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry
  232. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
  233. T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ⋅NO/cGMP Signaling
  234. Effect of Alirocumab on Mortality After Acute Coronary Syndromes
  235. Increased Lymphangiogenesis and Lymphangiogenic Growth Factor Expression in Perivascular Adipose Tissue of Patients with Coronary Artery Disease
  236. Educating Children for a Healthy Lifestyle
  237. Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial
  238. RENIN, ALDOSTERONE, THE ALDOSTERONE-TO-RENIN RATIO AND INCIDENT ARTERIAL HYPERTENSION AMONG NORMOTENSIVE SUBJECTS FROM THE POPULATION
  239. Sex-specific differences regarding seasonal variations of incidence and mortality in patients with myocardial infarction in Germany
  240. Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry
  241. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
  242. Up in the air: links between the environment and cardiovascular disease
  243. Air pollution, chronic smoking, and mortality
  244. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
  245. Center for Thrombosis and Hemostasis Mainz
  246. Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds
  247. Subtherapeutic Anticoagulation Control under Treatment with Vitamin K-Antagonists—Data from a Specialized Coagulation Service
  248. Vision-related quality of life considering both eyes: results from the German population-based Gutenberg Health Study (GHS)
  249. Choroidal thickness is associated with cardiovascular risk factors and cardiac health: the Gutenberg Health Study
  250. 5-Year Experience of In-Hospital Outcomes After Percutaneous Left Atrial Appendage Closure in Germany
  251. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry
  252. Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
  253. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany
  254. Relative Telomere Length and Cardiovascular Risk Factors
  255. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry
  256. Association of Low Birth Weight With Altered Corneal Geometry and Axial Length in Adulthood in the German Gutenberg Health Study
  257. Chronic occupational noise exposure: Effects on DNA damage, blood pressure, and serum biochemistry
  258. Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy in the USA and Europe
  259. Noninvasive peripheral vascular function and atrial fibrillation in the general population
  260. Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds
  261. The prevalence of visual impairment in the adult population
  262. Income and education predict elevated depressive symptoms in the general population: results from the Gutenberg health study
  263. Lysed Erythrocyte Membranes Promote Vascular Calcification
  264. Contribution of airborne desert dust to air quality and cardiopulmonary disease
  265. A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post myocardial infarction
  266. Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study
  267. The cardiovascular effects of noise
  268. Environmental noise induces the release of stress hormones and inflammatory signaling molecules leading to oxidative stress and vascular dysfunction—Signatures of the internal exposome
  269. Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants
  270. Indikation zur Therapie der Trikuspidalklappe bei rechts- und/oder linksventrikulären Erkrankungen
  271. Syncope in the German Nationwide inpatient sample – Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by higher in-hospital mortality
  272. Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis
  273. Somatic symptom load in men and women from middle to high age in the Gutenberg Health Study - association with psychosocial and somatic factors
  274. The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of having venous thromboembolism
  275. Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions
  276. Inducible Knockdown of Endothelial Protein Tyrosine Phosphatase-1B Promotes Neointima Formation in Obese Mice by Enhancing Endothelial Senescence
  277. Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis
  278. Impact of symptomatic atherosclerosis in patients with pulmonary embolism
  279. Left ventricular geometry and function in early repolarization: results from the population-based Gutenberg Health Study
  280. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events
  281. Antihypertensive Decapeptide From Cyanobacterium Spirulina platensis
  282. Common Genetic Variation in Relation to Brachial Vascular Dimensions and Flow-Mediated Vasodilation
  283. Impact of chronic obstructive pulmonary disease on the outcomes of patients with peripheral artery disease
  284. Die interdisziplinäre Notaufnahme im Zusammenspiel mit Chest Pain Units, Brustschmerzambulanzen und Cardiac Arrest Centern
  285. Assessing Planning Ability Across the Adult Life Span in a Large Population-Representative Sample: Reliability Estimates and Normative Data for the Tower of London (TOL-F) Task
  286. Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the “PSP” Technique
  287. Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome
  288. Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction
  289. New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease
  290. Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism
  291. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling
  292. Impact of atrial fibrillation on in-hospital mortality of ischemic stroke patients and identification of promoting factors of atrial thrombi – Results from the German nationwide inpatient sample and a single-center retrospective cohort
  293. The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation
  294. Oxidative Stress in Cardiac Tissue of Patients Undergoing Coronary Artery Bypass Graft Surgery: The Effects of Overweight and Obesity
  295. Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists
  296. Predictors of stent thrombosis and their implications for clinical practice
  297. Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample
  298. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
  299. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function
  300. Syncope in haemodynamically stable and unstable patients with acute pulmonary embolism – Results of the German nationwide inpatient sample
  301. Management of Oral Anti-Coagulation in Patients with Heart Failure—Insights from the ThrombEVAL Study
  302. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine
  303. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease
  304. Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patients
  305. Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up
  306. Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancer
  307. New onset of depression in aging women and men: contributions of social, psychological, behavioral, and somatic predictors in the community – CORRIGENDUM
  308. Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population‐Based Gutenberg Health Study
  309. First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a surgical-like Clover technique
  310. TCT-720 Right ventricular function as a predictor for mortality in TAVI patients
  311. Cross-Sectional Associations between Homoarginine, Intermediate Phenotypes, and Atrial Fibrillation in the Community—The Gutenberg Health Study
  312. Is assessment of depression equivalent for migrants of different cultural backgrounds? Results from the German population-based Gutenberg Health Study (GHS)
  313. Double hazard of smoking and alcohol on vascular function in adolescents
  314. New onset of depression in aging women and men: contributions of social, psychological, behavioral, and somatic predictors in the community
  315. Novel DNA Methylation Sites Influence GPR15 Expression in Relation to Smoking
  316. Effects of gaseous and solid constituents of air pollution on endothelial function
  317. Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study
  318. Predictors of early scaffold thrombosis
  319. Long-Term Prognosis of Patients With Takotsubo Syndrome
  320. The German CPU registry: Comparison of smokers and nonsmokers
  321. PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity
  322. A first dedicated Heart Valve Unit
  323. α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction
  324. Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)
  325. Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study
  326. Crucial role for Nox2 and sleep deprivation in aircraft noise-induced vascular and cerebral oxidative stress, inflammation, and gene regulation
  327. The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice
  328. Pulmonary Arterial Hypertension and Endothelial Dysfunction Is Linked to NADPH Oxidase-Derived Superoxide Formation in Venous Thrombosis and Pulmonary Embolism in Mice
  329. Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure
  330. Role of endothelial and macrophage tetrahydrobiopterin in development and progression of atherosclerosis: BH4 puzzle solved?
  331. Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain
  332. Association of ocular, cardiovascular, morphometric and lifestyle parameters with retinal nerve fibre layer thickness
  333. Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
  334. Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis
  335. Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds
  336. Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1
  337. Environmental stressors and cardiovascular risk: Impact of environmental noise exposure on vascular oxidative stress and damage
  338. Abstract 030: IL-17A Induces Vascular Dysfunction via Downregulation of eNOS Expression
  339. Multiple systemic embolic events in a patient undergoing primary percutaneous coronary intervention
  340. Abstract 147: The Role of Thrombin Generation in Cardiovascular Disease and Mortality - Results from the Population-based Gutenberg Health Study
  341. Associations between degree and sub-dimensions of depression and metabolic syndrome (MetS) in the community: results from the Gutenberg Health Study (GHS)
  342. Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets—Results from the Gutenberg Health Study
  343. Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis
  344. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” [Redox Biol. 13 (2017) 94–162]
  345. Acute deep vein thrombosis suppresses peripheral T cell effector function
  346. The Adverse Effects of Environmental Noise Exposure on Oxidative Stress and Cardiovascular Risk
  347. Environmental Stressors and Their Impact on Health and Disease with Focus on Oxidative Stress
  348. Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome
  349. Guideline-adherence regarding critical time intervals in the German Chest Pain Unit registry
  350. Coagulation and inflammation in long‐term cancer survivors: results from the adult population
  351. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study
  352. Epidemiology of traffic noise and cardiometabolic disease
  353. Pathophysiology of noise-induced cardiovascular diseases
  354. Introduction
  355. Future perspectives
  356. Summary
  357. Conclusions
  358. Strategies to mitigate cardiovascular effects of noise and air pollution
  359. Development and challenges over the next decade
  360. Inorganic nitrite and nitrate in cardiovascular therapy: A better alternative to organic nitrates as nitric oxide donors?
  361. Invasive treatment of NSTEMI patients in German Chest Pain Units – Evidence for a treatment paradox
  362. The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease
  363. Lack of T-bet reduces monocytic interleukin-12 formation and accelerates thrombus resolution in deep vein thrombosis
  364. Environmental Noise and the Cardiovascular System
  365. Editorial commentary: The air that I breathe……………..makes me sick!
  366. Sex-specific differences in mortality and the obesity paradox of patients with myocardial infarction ages >70 y
  367. Prävention von Herz-Kreislauf-Erkrankungen
  368. Gender differences in bicycle exercise stress echocardiography testing
  369. Gender-differences in prevalence and outcome of ischemic stroke and promoting factors of atrial thrombi
  370. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
  371. Einschätzung von Ärzten zur medizinischen Versorgung mit oralen Antikoagulanzien
  372. Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds
  373. Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R
  374. Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)
  375. Successful percutaneous coronary intervention for an in-stent chronic total occlusion in a patient with dextrocardia: a case report
  376. Pitfalls of cannulation for extracorporeal life support: review of the literature and illustrative case presentation
  377. The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats
  378. Refractive, corneal, and ocular residual astigmatism: distribution in a German population and age dependency—the Gutenberg Health Study
  379. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography...
  380. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EURegistry
  381. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis
  382. Time Response of Oxidative/Nitrosative Stress and Inflammation in LPS-Induced Endotoxaemia—A Comparative Study of Mice and Rats
  383. Emotional and tangible social support in a German population-based sample: Development and validation of the Brief Social Support Scale (BS6)
  384. Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan
  385. Urinary neutrophil gelatinase-associated lipocalin and cystatin C compared to the estimated glomerular filtration rate to predict risk in patients with suspected acute myocardial infarction
  386. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
  387. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
  388. Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
  389. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
  390. CD40L controls obesity-associated vascular inflammation, oxidative stress and endothelial dysfunction in mice - translational aspects for man
  391. Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment—Results from the Randomized TEAMSTA Protect I Trial
  392. Environmental Factors and Hypertension
  393. Subclinical levels of anxiety but not depression are associated with planning performance in a large population-based sample
  394. Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds
  395. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice
  396. Refractive, corneal and ocular residual astigmatism: distribution in a German population and age-dependency - the Gutenberg health study
  397. Successful transcatheter aortic valve-in-valve implantation in a patient having a chronic type A aortic dissection
  398. The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25) – reference data from the German population-based Gutenberg Health Study (GHS)
  399. GDF-15 predicts cardiovascular events in acute chest pain patients
  400. Peripheral artery disease, redox signaling, oxidative stress – Basic and clinical aspects
  401. Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species
  402. Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system
  403. Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis – Data from the Population-based Gutenberg Health Study
  404. Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis
  405. Impact of Oxidative Stress on the Heart and Vasculature
  406. Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system
  407. Environmental stressors and cardiovascular disease: the evidence is growing
  408. Transapical implantation of a transcatheter aortic valve prosthesis into a mitral annuloplasty ring guided by real-time three-dimensional cardiac computed tomography–fluoroscopy fusion imaging
  409. Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs
  410. e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study
  411. Does endothelial tetrahydrobiopterin control the endothelial NO synthase coupling state in arterial resistance arteries?
  412. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
  413. Transcatheter transapical left ventricle remodelling in ischaemic cardiomyopathy with apical aneurysm using 3rd generation 3D cardiac computed tomography fusion imaging
  414. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
  415. Chest Pain Unit Network in Germany
  416. FEV1 and FVC predict all-cause mortality independent of cardiac function — Results from the population-based Gutenberg Health Study
  417. Look Out—A Trap in the Cardiac Cath Lab
  418. Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function
  419. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort
  420. New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma
  421. Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
  422. The impact of pseudophakia on vision-related quality of life in the general population – The Gutenberg Health Study
  423. The Prevalence of Glaucoma in Young People
  424. Loneliness in the general population: prevalence, determinants and relations to mental health
  425. Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community‐Based Cohorts: A Meta‐Analysis
  426. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband
  427. Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions
  428. Characterization and referral patterns of ST-elevation myocardial infarction patients admitted to chest pain units rather than directly to catherization laboratories. Data from the German Chest Pain Unit Registry
  429. Brustschmerzambulanzen (BSA) und Chest Pain Units (CPU) – eine gelungene interaktive Kombination weiter auf dem Vormarsch
  430. Effects of noise on vascular function, oxidative stress, and inflammation: mechanistic insight from studies in mice
  431. Editor’s Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association
  432. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension
  433. Both flow-mediated dilation and constriction are associated with changes in blood flow and shear stress: Two complementary perspectives on endothelial function
  434. Mean Platelet Volume and Arterial Stiffness – Clinical Relationship and Common Genetic Variability
  435. Supervised exercise training in peripheral arterial disease increases vascular shear stress and profunda femoral artery diameter
  436. Pharmacology of Nitrovasodilators
  437. Noise Pollution and Arterial Hypertension
  438. Role of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide
  439. Steeper Iris Conicity Is Related to a Shallower Anterior Chamber: The Gutenberg Health Study
  440. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study
  441. Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension
  442. Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis
  443. Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction
  444. First Evidence of Complete Resorption 4 Years After Bioresorbable Scaffold Implantation in the Setting of ST-Segment Elevation Myocardial Infarction
  445. From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension
  446. Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE)
  447. Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014
  448. Pheochromocytoma triggers takotsubo syndrome complicated by cerebral and peripheral embolic events
  449. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients
  450. TCT-404 ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison
  451. TCT-401 Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with biOresorbable Scaffolding plaTforms in Europe) Registry
  452. A rare cause of excruciating chest pain mimicking acute coronary syndrome
  453. Cardiac arrhythmias in patients with Danon disease
  454. High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibrillation
  455. On versus off-hour care of patients with acute coronary syndrome and persistent ST-segment elevation in certified German chest pain units
  456. Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction
  457. NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathy
  458. [PP.35.03] ALDOSTERONE, RENIN AND THE ALDOSTERONE-TO-RENIN-RATIO
  459. Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population
  460. Transcatheter aortic valve implantation with the new-generation Evolut R™
  461. Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
  462. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice
  463. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry
  464. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry
  465. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. für „Brustschmerz-Ambulanzen“
  466. Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
  467. Reply
  468. Environmental stressors and cardio-metabolic disease: part I–epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies
  469. Environmental stressors and cardio-metabolic disease: part II–mechanistic insights
  470. Airborne disease: a case of a Takotsubo cardiomyopathie as a consequence of nighttime aircraft noise exposure
  471. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry
  472. Distribution of Anterior Chamber Angle Width and Correlation With Age, Refraction, and Anterior Chamber Depth—The Gutenberg Health Study
  473. Current and cumulative night shift work and subclinical atherosclerosis: results of the Gutenberg Health Study
  474. Targeting vascular (endothelial) dysfunction
  475. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison
  476. Association of Type D personality with cognitive functioning in individuals with and without cardiovascular disease — The Gutenberg Health Study
  477. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease—results from the large AtheroGene study
  478. Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance
  479. Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: possible role for the leptin-inflammation-fibrosis-hypoxia axis
  480. A systematic diagnostic and therapeutic approach for the treatment of patients after cardio-pulmonary resuscitation: a prospective evaluation of 212 patients over 5 years
  481. Noise Annoyance is Associated With Depression and Anxiety in the General Population- the Contribution of Aircraft Noise
  482. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice
  483. Noise Annoyance Is Associated with Depression and Anxiety in the General Population- The Contribution of Aircraft Noise
  484. Serial assessments of microvascular obstruction by contrast-enhanced magnetic resonance predict contractile recovery and clinical outcome after reperfused acute myocardial infarction
  485. Hypertension is strongly associated with false-positive bicycle exercise stress echocardiography testing results
  486. Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex
  487. Leukocyte–platelet aggregates—a phenotypic characterization of different stages of peripheral arterial disease
  488. Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure–volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort
  489. Formation of 2-nitrophenol from salicylaldehyde as a suitable test for low peroxynitrite fluxes
  490. Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
  491. PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study
  492. BENCHMARKING IN THE MYOCARDIAL INFARCTION REGISTRY RHEINLAND-PFALZ (MIR-RLP) RESULTED IN INCREASE IN PRE-HOSPITAL ECG-RECORDING AND REDUCTION IN ISCHEMIC TIME TO REPERFUSION IN STEMI
  493. Cardiac Computed Tomography in Certified German Chest Pain Units
  494. Bioresorbable Coronary Scaffold Thrombosis
  495. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents
  496. Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function
  497. Influence of exercise training on proangiogenic TIE-2 monocytes and circulating angiogenic cells in patients with peripheral arterial disease
  498. Erratum to: Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2015
  499. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
  500. Lumen Size Matters
  501. Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study
  502. Comparison of risk assessment strategies for not-high-risk pulmonary embolism
  503. Reference intervals of plasma homoarginine from the German Gutenberg Health Study
  504. ADMA and arginine derivatives in relation to non-invasive vascular function in the general population
  505. Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German–Austrian ABSORB RegIstRy (GABI-R)
  506. ADMA, subclinical changes and atrial fibrillation in the general population
  507. Severe Prinzmetal-Type Coronary Artery Spasm Causing Recurrent ST-Segment Elevation and Reversible Obstruction of a Bioresorbable Scaffold
  508. Distribution of antiphospholipid antibodies in a large population-based German cohort
  509. The Use of Echocardiography in Certified Chest Pain Units: Results from the German Chest Pain Unit Registry
  510. Platelet-Localized FXI Promotes a Glycoprotein Ib Alpha Dependent Feedback Loop in Arterial Hypertension and Vascular Inflammation
  511. Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese MiceSignificance
  512. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms
  513. History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism
  514. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans
  515. Redox Regulation of Dihydrofolate Reductase: Figure.
  516. Inflammation is associated with a reduced number of pro-angiogenic Tie-2 monocytes and endothelial progenitor cells in patients with critical limb ischemia
  517. Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population
  518. Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress
  519. Research highlights in interventional cardiology
  520. TCT-12 Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry
  521. Optical Coherence Tomography Findings in Bioresorbable Vascular Scaffolds Thrombosis
  522. Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction
  523. Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 LevelsCLINICAL PERSPECTIVE
  524. Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation
  525. Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease
  526. Guideline-adherence and perspectives in the acute management of unstable angina – Initial results from the German chest pain unit registry
  527. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats
  528. „Do not rescuscitate“ – Auswirkungen der Einführung eines standardisierten Formulars auf Therapiebegrenzungen in der klinischen Praxis
  529. The Incidence of Audible Steam Pops Is Increased and Unpredictable With the ThermoCool® Surround Flow Catheter During Left Atrial Catheter Ablation: A Prospective Observational Study
  530. Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay
  531. Estimation of Values below the Limit of Detection of a Contemporary Sensitive Troponin I Assay Improves Diagnosis of Acute Myocardial Infarction
  532. Angiotensin II to macrophage: Will you polarize? and when?
  533. Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014
  534. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications
  535. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project
  536. Rationale and design of the RE-LATED AF—AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus—Effects of Dabigatran in patients with Atrial Fibrillation
  537. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
  538. PHQ-2 and GAD-2 scores predict mortality in patients undergoing oral anticoagulation
  539. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
  540. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes
  541. Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program
  542. Distribution, genetic and cardiovascular determinants of FVIII:c — Data from the population-based Gutenberg Health Study
  543. Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries
  544. Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
  545. The Ophthalmic Branch of the Gutenberg Health Study: Study Design, Cohort Profile and Self-Reported Diseases
  546. Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study
  547. CardioPulse Articles
  548. Timing of Percutaneous Coronary Intervention in Troponin-negative Patients With Acute Coronary Syndrome Without Persistent ST-segment Elevation
  549. Correction
  550. THROMBOSIS AFTER BIORESORBABLE VASCULAR SCAFFOLD IMPLANTATION: ANGIOGRAPHIC AND OCT FINDINGS
  551. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest Pain Units“
  552. Feasibility and safety of left ventricular endomyocardial biopsy via transradial access: Technique and initial experience
  553. The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units
  554. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
  555. Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia
  556. Akutes Koronarsyndrom (außer STEMI)
  557. High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study
  558. Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison
  559. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL
  560. Editorial
  561. Organic nitrates: Update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction
  562. Genome-Wide Association Study of l -Arginine and Dimethylarginines Reveals Novel Metabolic Pathway for Symmetric Dimethylarginine
  563. Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
  564. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
  565. Multiple Biomarkers and Atrial Fibrillation in the General Population
  566. The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
  567. Low IL-10/TNFα Ratio in Patients with Coronary Artery Disease and Reduced Left Ventricular Ejection Fraction with a Poor Prognosis After 10 Years
  568. Maternal Treatment of Spontaneously Hypertensive Rats With Pentaerythritol Tetranitrate Reduces Blood Pressure in Female OffspringNovelty and Significance
  569. Medikamentöse Therapie der stabilen koronaren Herzerkrankung
  570. Die konservative Therapie der stabilen koronaren Herzerkrankung
  571. Stratifizierung des kardiovaskulären Risikos bei Patienten mit Typ-2-Diabetes
  572. Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program
  573. Two-vessel peri-scaffold staining and malapposition 12 months after bioresorbable scaffold implantation
  574. Evaluation of an iterative model–based reconstruction algorithm for low-tube-voltage (80 kVp) computed tomography angiography
  575. Immediate, Acute, and Subacute Thrombosis Due to Incomplete Expansion of Bioresorbable Scaffolds
  576. Adrenomedullin and Arterial Stiffness
  577. Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
  578. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
  579. Is At Least One Vitamin Helping Our Vasculature?
  580. TCT-331 Real-World Clinical Experience of Fractional Flow Reserve Assessed With a Rapid Exchange Pressure Sensor on a MicroCatheter
  581. TCT-611 Multimodality assessment 12 months after implantation of a bioresorbable scaffold for the treatment of culprit lesions in myocardial infarction
  582. TCT-403 Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-Term Blood Pressure Response in Renal Denervation Patients
  583. Nighttime aircraft noise impairs endothelial function and increases blood pressure in patients with or at high risk for coronary artery disease
  584. Inflammatory Monocytes Determine Endothelial Nitric-oxide Synthase Uncoupling and Nitro-oxidative Stress Induced by Angiotensin II
  585. Associations between Depression and Diabetes in the Community: Do Symptom Dimensions Matter? Results from the Gutenberg Health Study
  586. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction
  587. Complaints of Sleep Disturbances Are Associated with Cardiovascular Disease: Results from the Gutenberg Health Study
  588. Usefulness of 3D-PISA as compared to guideline endorsed parameters for mitral regurgitation quantification
  589. A 48-year-old woman with panic attacks
  590. eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation
  591. Obere gastrointestinale Blutung mit hämorrhagischem Schock am Ende einer Urlaubsreise: Präklinische und innerklinische Versorgung eines gastrointestinalen Notfalls
  592. Effects of empagliflozin on oxidative stress and endothelial dysfunction in STZ-induced Type 1 diabetic rat
  593. Reduction of ICD Shock Burden by Eliminating Back-Up Pacing Induced Ventricular Tachyarrhythmias
  594. Anatomic Stabilization and Functional Normalization of a Ruptured Coronary Plaque 12 Months After Implantation of a Bioresorbable Scaffold
  595. Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, cont...
  596. Assessment of microRNAs in patients with unstable angina pectoris
  597. Evaluation of oral anticoagulation therapy: Rationale and design of the thrombEVAL study programme
  598. Aktuelle Koronarstenttechnologie
  599. Cardiovascular effects of environmental noise exposure
  600. Absorb bioresorbable scaffold implantation for the treatment of an ostial chronic total occlusion
  601. IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
  602. Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study
  603. CRT-100 A Systematic Diagnostic and Therapeutic Approach for the Treatment of Patients After Cardio-Pulmonary Resuscitation: A Prospective Evaluation of 212 Patients During 5 Years
  604. Antibodies against biologicals and acute coronary syndromes
  605. Glutathione Peroxidase-1 Deficiency Potentiates Dysregulatory Modifications of Endothelial Nitric Oxide Synthase and Vascular Dysfunction in Aging
  606. Mitochondrial Redox Signaling: Interaction of Mitochondrial Reactive Oxygen Species with Other Sources of Oxidative Stress
  607. Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species—Studies in White Blood Cells and in Animal Models
  608. In vitro and in vivo Characterization of a New Organic Nitrate Hybrid Drug Covalently Bound to Pioglitazone
  609. Vascular Redox Signaling, Redox Switches in Endothelial Nitric Oxide Synthase (eNOS Uncoupling), and Endothelial Dysfunction
  610. Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes
  611. Combining Cross-sectional Data on Prevalence with Risk Estimates from a Prediction Model
  612. Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches
  613. Endothelial dysfunction after stenting and scaffolding of coronary arteries
  614. Predictive value of brachial reactive hyperemia and flow-mediated dilation in stable coronary artery disease
  615. A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review
  616. Neue Aspekte in der Pathophysiologie der Herzinsuffizienz sowie deren therapeutische Implikationen
  617. Depression in Atrial Fibrillation in the General Population
  618. Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study
  619. The Role of DNA Damage in the Pathogenesis of Nitrate Tolerance
  620. Effects of Sodium dependent Glucose Transporter 2 (SGLT2) Inhibition with Empagliflozin on Oxidative Stress and Endothelial Dysfunction in STZ-Induced Type I Diabetic Rat
  621. Comparison of Linagliptin, Sitagliptin and Liraglutide Effects on Survival and Vascular Complications in Experimental Sepsis
  622. Vascular Dysfunction and Oxidative Stress in Diabetic Rats - Comparison of Beneficial Effects of AT1- Receptor Blockade, Calcium Antagonist, or Combination Therapy
  623. TCT-783 Transient and Permanent Cardiac Conduction Abnormalities Following Transcatheter Aortic Valve Implantation
  624. Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry
  625. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial
  626. CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction
  627. The German CPU Registry: Comparison of troponin positive to troponin negative patients
  628. Oxidative stress, endothelial biomarkers and non-invasive vascular function in the general population in health and disease
  629. Differential Associations of Depressive Symptom Dimensions with Cardio-Vascular Disease in the Community: Results from the Gutenberg Health Study
  630. GUESS-ing Polygenic Associations with Multiple Phenotypes Using a GPU-Based Evolutionary Stochastic Search Algorithm
  631. Deletion of peroxisome proliferator coactivator-1alpha accelerates angiotensin II induced endothelial dyfunction by increasing mitochondrial oxidative stress
  632. The interaction between circadian rhythms of endothelial function: resting versus recruitable endothelial function
  633. Determinants of arterial stiffness in pre- and postmenopausal women
  634. Cardiovascular effects of nocturnal aircraft noise on healthy volunteers
  635. ABSORB everolimus-eluting bioresorbable vascular scaffold systems for the sealing of unstable plaques
  636. Value of color doppler jet area for grading regurgitation severity in patients with secondary mitral regurgitation - better than its reputation?
  637. Association between genome-wide significant variants on gene expression and glutathione peroxidase-1 levels in the general population
  638. Predictors of self-reported heart failure - results from the Gutenberg Health study
  639. Diagnosis of acute myocardial infarction: super-sensitivity vs. high-sensitivity cardiac troponin I assay
  640. Smoking-induced preconditioning: acute, but not chronic, smoking paradoxically protects the endothelium from ischemia and reperfusion
  641. Effect of antihypertensive treatment with a combination of telmisartan and amlodipine on vascular structure and function
  642. Association between multiple biomarkers and classical risk factors with early carotid atherosclerosis
  643. Gender-specific diagnosis of acute myocardial infarction using high-sensitivity assayed cardiac troponin I
  644. Patients with peripheral arterial disease show an ameliorated proinflammatory status over 12 months non-supervised exercise training parallel to an increased walking distance
  645. Cardiac biomarkers and arterial stiffening: data from the Gutenberg Health study
  646. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay
  647. Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils
  648. More answers to the still unresolved question of nitrate tolerance
  649. History of depression but not current depression is associated with signs of atherosclerosis: data from the Gutenberg Health Study
  650. Effect of nighttime aircraft noise exposure on endothelial function and stress hormone release in healthy adults
  651. The impact of gender on fractional flow reserve measurements
  652. Sex differences in noninvasive vascular function in the community
  653. Kardiorenales Syndrom
  654. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease
  655. Angiotensin II–Induced Vascular Dysfunction Depends on Interferon-γ–Driven Immune Cell Recruitment and Mutual Activation of Monocytes and NK-Cells
  656. Association of hypertension with depression in the community
  657. How should I treat a patient with typical angina, typical angiography, negative FFR?
  658. Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia
  659. Association between chronic periodontal and apical inflammation and acute myocardial infarction
  660. Protein Tyrosine Nitration and Thiol Oxidation by Peroxynitrite—Strategies to Prevent These Oxidative Modifications
  661. Treatment of coronary bifurcation lesions: stent-covering of the side branch with and without PCI of the side branch: a retrospective analysis of all consecutive patients
  662. Nitrate therapy and nitrate tolerance in patients with coronary artery disease
  663. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application
  664. ACUTE, BUT NOT CHRONIC, SMOKING PARADOXICALLY PROTECTS THE ENDOTHELIUM FROM ISCHEMIA AND REPERFUSION
  665. Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats
  666. Acute (but not chronic) smoking paradoxically protects the endothelium from ischemia and reperfusion: insight into the “smoking paradox”
  667. Coronary artery disease: seeing or foreseeing?
  668. CRT-37 Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With And Without PCI Of The Side Branch - A Retrospective Analysis Of All Consecutive Patients
  669. An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling
  670. Genome-Wide Haplotype Analysis of Cis Expression Quantitative Trait Loci in Monocytes
  671. Graphical Modeling of Gene Expression in Monocytes Suggests Molecular Mechanisms Explaining Increased Atherosclerosis in Smokers
  672. Immediate effect of the MitraClip(R) procedure on mitral ring geometry in primary and secondary mitral regurgitation
  673. Associations between depression and different measures of obesity (BMI, WC, WHtR, WHR)
  674. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study
  675. Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects
  676. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain
  677. A 22-year old female with cardiogenic shock due to transplant vasculopathy with severe left main stenosis
  678. Heparin–polynitroxides: Synthesis and preliminary evaluation as cardiovascular EPR/MR imaging probes and extracellular space-targeted antioxidants
  679. Increased Circulating Levels of 3-Nitrotyrosine Autoantibodies
  680. Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1? Deficiency Accelerates Endothelial Dysfunction during Chronic Angiotensin II Treatment by Increasing Mitochondrial Oxidative Stress and Vascular Aging
  681. Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome
  682. Enhanced Age-Dependent ENOS Dysfunction and - Uncoupling in Glutathione Peroxidase-1-Deficient Mice
  683. Self-referral to chest pain units: results of the German CPU-registry
  684. Diagnostic and Prognostic Performance of Myeloperoxidase Plasma Levels Compared With Sensitive Troponins in Patients Admitted With Acute Onset Chest Pain
  685. TCT-895 Prediction of implanted TAVI prosthetic size by 3D-TEE assessment
  686. Comprehensive Exploration of the Effects of miRNA SNPs on Monocyte Gene Expression
  687. Multiple Endothelial Biomarkers and Noninvasive Vascular Function in the General Population
  688. Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
  689. Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the “German chest pain unit registry”
  690. α1AMP-Activated Protein Kinase Mediates Vascular Protective Effects of Exercise
  691. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease
  692. Impairment of the extrusion transporter for asymmetric dimethyl-l-arginine: A novel mechanism underlying vasospastic angina
  693. Die Gutenberg Gesundheitsstudie
  694. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression
  695. Hyperglycemia and oxidative stress in cultured endothelial cells – a comparison of primary endothelial cells with an immortalized endothelial cell line
  696. Molecular mechanisms of the crosstalk between mitochondrial and NADPH oxidase derived reactive oxygen species in white blood cells — Implications for cardiovascular diseases
  697. Lysozyme M positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction
  698. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase — Beneficial effects of therapy with the AT1-receptor blocker telmisartan
  699. Comparison of direct and indirect antioxidant effects of linagliptin with other gliptins — Evidence for antioxidant and antiinflammatory properties of linagliptin
  700. Atrial Fibrillation
  701. CardioPulse Articles
  702. Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
  703. Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates
  704. Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies
  705. Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation
  706. Oxidative Stress, Endothelial Dysfunction, and Its Impact on Smooth Muscle Signaling
  707. CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease – IVUS substudy of the ENCORE trials
  708. Characterization of New Organic Nitrate Hybrid Drugs Covalently Bound to Valsartan and Cilostazol
  709. Chronic Inflammatory Cardiomyopathy of Interferon γ–Overexpressing Transgenic Mice Is Mediated by Tumor Necrosis Factor-α
  710. The T Helper 1 Transcription Factor T Box Expressed in T Cells Is a Mediator of Angiotensin II Induced Inflammation, Vascular Dysfunction and Oxidative Stress in the Murine Vasculature
  711. Whole Blood of Patients with Peripheral Arterial Disease Shows an Increased Production of Reactive Oxygen Species and a Proinflammatory Phenotype
  712. CD40 Ligand Deficiency Attenuates Angiotensin II Induced Oxidative Stress and Endothelial Dysfunction in a Murine Model of Arterial Hypertension
  713. Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero Gene Study
  714. Apixaban
  715. Endothelial function and hemorheological parameters modulate coronary blood flow in patients without significant coronary artery disease
  716. Evidence of a weak correlation between peripheral endothelial function measures and carotid intima-media thickness
  717. Parameters of blood viscosity do not correlate with the extent of coronary and carotid atherosclerosis and with endothelial function in patients undergoing coronary angiography
  718. Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease
  719. Type D Personality as a Cardiovascular Risk Marker in the General Population: Results from the Gutenberg Health Study
  720. Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction
  721. Integrating Genome-Wide Genetic Variations and Monocyte Expression Data Reveals Trans-Regulated Gene Modules in Humans
  722. Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial Infarction
  723. Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study
  724. Reduktion der stationären Verweildauer bei Patienten mit akutem Koronarsyndrom durch Einrichtung einer Chest Pain Unit
  725. Changes in endothelial function in healthy volunteers during soccer World Cup 2010 games
  726. Molecular Mechanisms of the Crosstalk Between Mitochondrial and NADPH Oxidase Derived Reactive Oxygen Species in White Blood Cells – Implications for Cardiovascular Diseases
  727. Glutathione Peroxidase-1-Deficiency Enhances Age-Dependent Vascular Dysfunction
  728. Chronic Therapy With Isosorbide-5-Mononitrate Causes Endothelial Dysfunction, Oxidative Stress and a Marked Increase in Vascular Endothelin-1 Expression
  729. Reconstitution of Myelomonocyte-Depleted Mice With Monocytes, But Not With Neutrophils, Reestablishes Arterial Hypertension and Oxidative Stress in Response To Angiogtensin II
  730. Influence of sex and genetic variability on expression of X-linked genes in human monocytes
  731. Vascular Dysfunction in Experimental Diabetes is Associated With Cardiovascular Oxidative Stress, Loss in ecSOD Activity, Enos Uncoupling and Improved by Pentaerithrityl Tetranitrate – Role for heme oxygenase-1 and NRF2
  732. Intracellular pH: Figure.
  733. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene
  734. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress
  735. Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation andS-Glutathionylation of Endothelial Nitric Oxide Synthase
  736. Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
  737. Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease
  738. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
  739. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque
  740. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
  741. The Choice of the Filtering Method in Microarrays Affects the Inference Regarding Dosage Compensation of the Active X-Chromosome
  742. Human metabolic individuality in biomedical and pharmaceutical research
  743. Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes
  744. Biological effects of low-dose radiation: of harm and hormesis
  745. Psychosomatik und Psychotherapie der koronaren Herzerkrankung
  746. Vascular Dysfunction in Experimental Diabetes Is Improved by Pentaerithrityl Tetranitrate but Not Isosorbide-5-Mononitrate Therapy
  747. A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease
  748. β-Blockers in Patients With Intermittent Claudication and Arterial Hypertension
  749. Noninvasive Vascular Function Measurement in the Community
  750. A case of coronary hypersensitivity (Kounis) syndrome associated with mid-ventricular ballooning pattern, intracoronary thrombosis and troponin elevation
  751. Sex Differences in Early Carotid Atherosclerosis (from the Community-Based Gutenberg-Heart Study)
  752. Nitrate Therapy
  753. Inorganic Nitrate Therapy Improves Doxorubicin-Induced Cardiomyopathy
  754. Prevalence of distress, comorbid conditions and well being in the general population
  755. Oxidative stress and endothelial dysfunction in hypertension
  756. Making it More Sensitive
  757. MYELOPEROXIDASE AS EARLY DIAGNOSTIC AND PROGNOSTIC MARKER OF ACUTE CORONARY SYNDROME: A HEAD-TO-HEAD COMPARISON WITH HIGH SENSITIVE TROPONIN I
  758. CIRCULATING AND INFILTRATING MONOCYTIC CELLS MEDIATE ANGIOTENSIN-II INDUCED ARTERIAL HYPERTENSION
  759. Betulinic acid protects against cerebral ischemia–reperfusion injury in mice by reducing oxidative and nitrosative stress
  760. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
  761. α1AMP-Activated Protein Kinase Preserves Endothelial Function During Chronic Angiotensin II Treatment by Limiting Nox2 Upregulation
  762. Oxidative stress and endothelial dysfunction: Therapeutic implications
  763. Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophilesin Vitro
  764. Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction
  765. Vascular Dysfunction in Streptozotocin-Induced Experimental Diabetes Strictly Depends on Insulin Deficiency
  766. Association of Serum Procalcitonin With Cardiovascular Prognosis in Coronary Artery Disease
  767. Chronic pharmacological preconditioning against ischemia
  768. Endothelium and hyperviscosity
  769. Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure
  770. Inflammatory markers and cardiovascular risk in the metabolic syndrome
  771. Peripheral hemorheological and vascular correlates of coronary blood flow
  772. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies
  773. Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates
  774. Flow-mediated constriction: further insight into a new measure of vascular function
  775. Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation
  776. Is oxidative stress a therapeutic target in cardiovascular disease?
  777. Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension
  778. Multiple marker approach to risk stratification in patients with stable coronary artery disease
  779. Tako-Tsubo syndrome: dying of a broken heart?
  780. Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway
  781. Type-D personality and depersonalization are associated with suicidal ideation in the German general population aged 35–74: Results from the Gutenberg Heart Study
  782. Distribution and Categorization of Left Ventricular Measurements in the General Population
  783. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk
  784. Mechanismen und klinischer Stellenwert der Nitrattoleranz. Diversität und Nebenwirkungen organischer Nitrate
  785. Therapie der koronaren Herzerkrankung mit NO-Donatoren. Nach wie vor eine wichtige Option
  786. Patientenzufriedenheit beim akuten Koronarsyndrom
  787. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1—evidence for direct and indirect antioxidant actions of bilirubin
  788. Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study
  789. Das akute Koronarsyndrom
  790. Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice
  791. C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S–independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies
  792. Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts
  793. P378 RESVERATROL REVERSES eNOS UNCOUPLING: IMPLICATION OF SIRT1
  794. Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility
  795. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
  796. New loci associated with kidney function and chronic kidney disease
  797. Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
  798. A Follow-Up Study of a Genome-wide Association Scan Identifies a Susceptibility Locus for Venous Thrombosis on Chromosome 6p24.1
  799. A Follow-Up Study of a Genome-wide Association Scan Identifies a Susceptibility Locus for Venous Thrombosis on Chromosome 6p24.1
  800. Pentaerythritol Tetranitrate Improves Angiotensin II–Induced Vascular Dysfunction via Induction of Heme Oxygenase-1
  801. A 34-year-old man with cardiac arrhythmias and lymphadenopathy
  802. Drug-Eluting Stent-Induced Vascular Dysfunction
  803. Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study
  804. Atrial fibrillation is associated with cardiac hypoxia
  805. Depression and disease severity as correlates of everyday physical activity in heart transplant candidates
  806. Organic Nitrates and Nitrate Tolerance—State of the Art and Future Developments
  807. Lesions of the Mitral Valve as a Cause of Central Retinal Artery Occlusion: Presentation and Discussion of Two Cases
  808. Comparison of Direct and Indirect Antioxidant Effects of Linagliptin (BI 1356, ONDERO) with other Gliptins – Evidence for Anti-inflammatory Properties of Linagliptin
  809. Regulation of Human ALDH-2 Activity by Electrophiles – Implications for Organic Nitrate Induced Tolerance, Oxidative Stress and Reactive Fatty Acid Metabolites in MI
  810. Vascular Dysfunction in Nitroglycerininduced Nitrate Tolerance is Improved by Telmisartan Therapy — Suppression of the RAAS and PKC Pathway
  811. Lysozyme-M Positive Myelomonocytic cells Mediate Angiotensin-II induced Arterial Hypertension
  812. Vascular Dysfunction in Streptozotocininduced Experimental Diabetes Strictly Depends on Insulin Deficiency
  813. Local Transient Myocardial Liposomal Gene Transfer of Inducible Nitric Oxide Synthase Does Not Aggravate Myocardial Function and Fibrosis and Leads to Moderate Neovascularization in Chronic Myocardial Ischemia in Pigs
  814. Endothelial functions: Translating theory into clinical application
  815. Ischemic and non-ischemic preconditioning: Endothelium-focused translation into clinical practice
  816. Improved outcome in acute coronary syndrome by establishing a chest pain unit
  817. Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study
  818. Endotheliale Dysfunktion: Ursachen und prognostische Bedeutung
  819. Extensive characterization of the human DDAH1 transgenic mice
  820. CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease—The ENCORE Trials
  821. Nachruf zum Tod von Professor Dr. med. Helmut Drexler
  822. Hypoxia and Myocardial Remodeling in Human Cardiac Allografts: A Time-course Study
  823. Differential VASP phosphorylation controls remodeling of the actin cytoskeleton
  824. Nebivolol
  825. Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference
  826. Characterization of the Antioxidant Properties of Pentaerithrityl Tetranitrate (PETN)-Induction of the Intrinsic Antioxidative System Heme Oxygenase-1 (HO-1)
  827. Nitrate Reductase Activity of Mitochondrial Aldehyde Dehydrogenase (ALDH-2) as a Redox Sensor for Cardiovascular Oxidative Stress
  828. Entwicklung der Chest-Pain-Units in Deutschland
  829. Die JUPITER-Studie: Antworten und Fragen?
  830. Prognostische Bedeutung der Stressechokardiografie
  831. Lipoprotein-associated phospholipase A2, a marker of vascular inflammation and systemic vulnerability
  832. Effects of selective If-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy
  833. Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
  834. Evidence for a negative inotropic effect of obesity in human myocardium?☆
  835. Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure
  836. Genetic Variants Associated With Cardiac Structure and Function
  837. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study
  838. Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosis
  839. A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena
  840. Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease
  841. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study
  842. Usefulness of MRI to Differentiate Between Temporary and Long-Term Coronary Artery Occlusion in a Minimally Invasive Model of Experimental Myocardial Infarction
  843. Die Rolle der Chest Pain Unit im Rahmen der Notfallaufnahme
  844. Wie nützlich sind die Algorithmen zur Differentialdiagnostik der monomorphen Tachykardien mit breitem QRS Komplex in kardiologischen Notfällen?
  845. Response to Letter Regarding Article, “Different Calculations of Ankle Brachial Index and Their Impact on Cardiovascular Risk Prediction”
  846. Akuter Thoraxschmerz: Chest-Pain-Unit – die Zertifizierungskampagne der Deutschen Gesellschaft für Kardiologie
  847. Ivabradin – eine neue Therapieoption bei kardiogenem Schock?
  848. Kardiale Notfälle: neue Lösungen für alte Probleme
  849. Wie nützlich sind die Algorithmen zur Differentialdiagnostik der monomorphen Tachykardien mit breitem QRS-Komplex in kardiologischen Notfällen?
  850. Association between Chronic Dental Infection and Acute Myocardial Infarction
  851. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: Results of the randomized, double-blind, placebo-controlled INEF study
  852. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm
  853. Decision for aggressive therapy in acute pulmonary embolism: implication of elevated troponin T
  854. Monitoring White Blood Cell Mitochondrial Aldehyde Dehydrogenase Activity: Implications for Nitrate Therapy in Humans
  855. From Menace to Marvel
  856. Selektive Herzfrequenzreduktion mit Ivabradin bei der stabilen koronaren Herzerkrankung
  857. Mitochondrial aldehyde dehydrogenase (ALDH-2)—Maker of and marker for nitrate tolerance in response to nitroglycerin treatment
  858. When Metabolism Rules Perfusion
  859. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
  860. Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress
  861. Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
  862. Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging
  863. Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGenestudy
  864. Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation
  865. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
  866. Regulation of erythrocyte survival by AMP-activated protein kinase
  867. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease
  868. Herzfrequenzreduktion bei der stabilen Angina pectoris und Ergebnisse zu Ivabradin
  869. Doubt about an essential role for constitutive nitric oxide synthase in nitroglycerin-mediated vasodilation
  870. PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGeneStudy
  871. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients*
  872. NOX5, a New “Radical” Player in Human Atherosclerosis?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
  873. Endotheliale Dysfunktion: Pathophysiologie, Diagnostik und prognostische Bedeutung
  874. Catheter ablation of an incessant ventricular tachycardia originating from the left aortic sinus cusp in an adolescent with subacute myocarditis
  875. Age-related atrial fibrosis
  876. Geschlechtsspezifische negative inotrope Wirkung von Übergewicht?
  877. Neue Erkenntnisse bei der Nitratwirkung, Nitratbioaktivierung und Toleranzentwicklung
  878. Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
  879. Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction
  880. Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction
  881. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest-Pain-Units“
  882. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
  883. Herzfrequenzreduktion bei der stabilen Angina pectoris und Ergebnisse zu Ivabradin
  884. Nitroglycerin Hits the Nerve
  885. Inflammatory pathways in patients with heart failure and preserved ejection fraction
  886. Anticoagulant and/or Antiplatelet Treatment in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
  887. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
  888. Different Calculations of Ankle-Brachial Index and Their Impact on Cardiovascular Risk Prediction
  889. First Evidence for a Crosstalk Between Mitochondrial and NADPH Oxidase-Derived Reactive Oxygen Species in Nitroglycerin-Triggered Vascular Dysfunction
  890. Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction
  891. Cyclooxygenase 2-Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs Induce Oxidative Stress by Up-Regulating Vascular NADPH Oxidases
  892. Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome
  893. Nitric Oxide, Tetrahydrobiopterin, Oxidative Stress, and Endothelial Dysfunction in Hypertension
  894. Sirolimus-Induced Vascular Dysfunction
  895. Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
  896. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
  897. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
  898. Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease
  899. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study
  900. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study
  901. ALDH-2 deficiency increases cardiovascular oxidative stress---Evidence for indirect antioxidative properties
  902. A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: Results of a double-blind, randomized study
  903. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction
  904. O44. Inhibition of CD98-associated amino acid transporters by dinitrosyl iron complexes
  905. Inflammation, atherosclerotic burden and cardiovascular prognosis
  906. Oxidative Inhibition of the Mitochondrial Aldehyde Dehydrogenase Promotes Nitroglycerin Tolerance in Human Blood Vessels
  907. Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro
  908. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance
  909. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function
  910. AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease
  911. Nitroglycerine causes mitochondrial reactive oxygen species production: In vitro mechanistic insights
  912. Chest Pain Unit (CPU): erste Erfahrungen in Mainz
  913. Endothelin-1 in Humans Is Increased by Oxygen-Derived Radicals Ex Vivo and In Vivo
  914. Heme Oxygenase-1
  915. Interferon-γ Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice
  916. Versorgung des akuten Koronarsyndromsin einer Chest Pain Unit - Eine sinnvolle Neuerung in Deutschland
  917. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study
  918. Impact of Metabolic Syndrome on Atherosclerotic Burden and Cardiovascular Prognosis
  919. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation
  920. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress
  921. Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxide
  922. Targeting Heme-Oxidized Soluble Guanylate Cyclase
  923. Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
  924. Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress
  925. Glutathione Peroxidase-1 Activity, Atherosclerotic Burden, and Cardiovascular Prognosis
  926. Do We Still Need Organic Nitrates?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
  927. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2−/− mice
  928. Nitratbehandlung
  929. Role of Reduced Lipoic Acid in the Redox Regulation of Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity
  930. Mechanisms underlying dysfunction of carotid arteries in genetically hyperlipidemic rabbits
  931. Pathogenese und Therapie des akuten Koronarsyndroms differenzieller Nutzen von GPIIb/IIIa-Rezeptorantagonisten bei Hochrisikopatienten
  932. Inhibition of Restenosis Development after Mechanical Injury: A New Field of Application for Malononitrilamides?
  933. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy
  934. Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats
  935. Normalization of endothelial dysfunction and vascular oxidative stress by chronic atorvastatin treatment in a rat model of streptozotocin-induced diabetes mellitus (type I)
  936. the role of mitochondrial aldehyde dehydrognase (ALDH-2) for bioactivation of organic nitrates: “Proof of concept” through investigations in ALDH-2 knockout mice
  937. Anti-oxidative effects in response to pentaerithrityl tetranitrate (PETN) treatment are mediated by heme oxygenase-1 and ferritin induction and prevent the development of nitrate tolerance and cross-tolerance in vivo
  938. Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions
  939. Revascularisation of a Giant Coronary Artery Aneurysm in Suspected Incomplete Kawasaki-Disease
  940. NADPH Oxidase Accounts for Enhanced Superoxide Production and Impaired Endothelium-Dependent Smooth Muscle Relaxation in BKβ1 −/− Mice
  941. Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
  942. Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk
  943. COX-2, Another Important Player in the Nitric Oxide–Endothelin Cross-Talk
  944. Reversal of Endothelial Nitric Oxide Synthase Uncoupling and Up-Regulation of Endothelial Nitric Oxide Synthase Expression Lowers Blood Pressure in Hypertensive Rats
  945. The selective estrogen receptor-β agonist biochanin A shows vasculoprotective effects without uterotrophic activity
  946. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
  947. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study
  948. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
  949. Endothelial Nitric Oxide Synthase in Vascular Disease
  950. Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2
  951. B-Type Natriuretic Peptide and the Risk of Cardiovascular Events and Death in Patients With Stable Angina
  952. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina
  953. Shunting of the Microcirculation After Mesenteric Ischemia and Reperfusion Is a Function of Ischemia Time and Increases Mortality
  954. Th-W51:7 Non-steroidal anti-inflammatory drugs up-regulate NADPH oxidase expression in spontaneously hypertensive rats
  955. Anti-Inflammatory Treatment with Standardized Human Serum Protein Solution Reduces Local and Systemic Inflammatory Response after Hemorrhagic Shock
  956. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure
  957. Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy
  958. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease
  959. The Oxidative Stress Concept of Nitrate Tolerance and the Antioxidant Properties of Hydralazine
  960. Explaining the Phenomenon of Nitrate Tolerance
  961. Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease
  962. Medikamentöse Therapie beim Patienten mit stabiler Angina pectoris
  963. Medikamentöse Therapie beim Patienten mit stabiler Angina pectoris (Antwortbogen)
  964. Medikamentöse Therapie beim Patienten mit stabiler Angina pectoris (Fragebogen)
  965. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4
  966. Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase
  967. Nω-hydroxy-l-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents
  968. Glutathione Peroxidase-1 and Homocysteine for Cardiovascular Risk Prediction
  969. Preoperative Cardiovascular Evaluation Before Non-Cardial Surgery
  970. Should Treatment of Sepsis Include Statins?
  971. Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis
  972. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease
  973. Ist eine Therapie mit organischen Nitraten heute noch sinnvoll?
  974. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins
  975. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study
  976. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion
  977. Surgical revision of an uncommonly dislocated self-expanding Amplatzer septal occluder device
  978. Emergency localization of radioactive seeds lost during intracoronary brachytherapy
  979. Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate
  980. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA
  981. Clinical aspects of reactive oxygen and nitrogen species
  982. Detection of Superoxide and Peroxynitrite in Model Systems and Mitochondria by the Luminol Analogue L-012
  983. 880-4 Intracoronary brachytherapy protects bifurcation lesions
  984. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
  985. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
  986. Chronic Arterial Responses to Polymer-Controlled Paclitaxel-Eluting Stents
  987. Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012
  988. ADMA and oxidative stress
  989. NADPH oxidose in the failins human heart: Reply
  990. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
  991. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance
  992. Does Nitric Oxide Mediate the Vasodilator Activity of Nitroglycerin?
  993. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts
  994. Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
  995. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing
  996. Diabetes mellitus, oxidative stress and endothelial dysfunction
  997. A new pitfall in detecting biological end products of nitric oxide—nitration, nitros(yl)ation and nitrite/nitrate artefacts during freezing
  998. The failing human heart
  999. Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells
  1000. Effects of metoprolol on oxidant stress parameters and nitric oxide bioavailability in angiotensin II induced hypertension

Showing 1,000 Stories.